ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP32-24 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2024
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအ့ဖြ့ၣ် 10, 2024
တၢ်ဃုသ့ၣ်ညါတၢ်အစၢ
တၢ်ပာ်ဖျါ 1221 - 1230 လၢ 5101 အစၢတဖၣ်အကျါ
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
bc-mhcp-pharmprogpolicynotifctn-eff-5-1-24.pdf
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
bc-mhcp-pharmprogpolicynotifctn-eff-4.12.24.pdf
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
bc-mhcp-pharmprogpolicynotifctn-eff-4.9.24.pdf
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP30-24 Update for New to Market Medical Drugs: prademagene zamikeracel and marnetegragene autotemcel
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအ့ဖြ့ၣ် 10, 2024
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP33-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective May 1, 2024
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအ့ဖြ့ၣ် 10, 2024
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP31-24 Rare Disease Benefit Mandate
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအ့ဖြ့ၣ် 10, 2024
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
2024 April Bulletins
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါအ့ဖြ့ၣ် 01, 2024
ကျိၣ်စ့တၢ်ဂ့ၢ်တၢ်ကျိၤ
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
medicaid-em-014-online-digital-evaluation-and-management-services.pdf
ကျိၣ်စ့တၢ်ဂ့ၢ်တၢ်ကျိၤ
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
commercial-si-02-split-surgical-package.pdf